Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS

Stopped early · Phase 1

Conditions studied: Multiple Sclerosis

In brief

Several investigations have suggested that polyunsaturated fatty acids may promote therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent disability progression in patients with relapsing MS.This study will seek to measure disease activity as seen on MRI scans in addition to measuring relapse rates.

Key facts

Study ID
NCT00638196
Run by
University of Rochester
People needed
9
Starts
2008-03-01
Expected to finish
2012-09-01
Last updated by the study team
2015-08-11

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.